Beta Fund
VC Fund
Newton, United States
Beta Fund is an early-stage venture fund focused on emerging high-tech and biotechnology companies.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 4%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Beta Fund invests in
BiotechnologyMobileSoftwareMedical DeviceHealth Care
Stages Beta Fund invests in
Series AFunding RoundSeedSeries BDebt Financing
Countries Beta Fund invests in
United StatesChina
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Norman Meisner
|
|||
Investment Focus
Industry
- Biotechnology 6 (26%)
- Mobile 4 (17%)
- Software 4 (17%)
- Medical Device 4 (17%)
- Health Care 3 (13%)
Stage
- Series A 5 (22%)
- Funding Round 5 (22%)
- Seed 4 (17%)
- Series B 3 (13%)
- Debt Financing 1 (4%)
Country
- United States 14 (61%)
- China 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Bill Johnson
CFO
|
CFO | Total investments: 0 | Find email | |
Dan Von Kohorn
Principal
|
Principal | Total investments: 1 | Find email | |
|
Norman Meisner
Principal
|
Principal | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Bangyao Biological
|
Bangyao Biological is a gene pharmaceutical company focusing on biological research activities and pharmaceutical development. | Series B / Nov 14, 2022 | |
ViralGains
|
ViralGains is a video ad journey platform that enables marketers to engage people with relevant brand stories in the contexts that people most favor. Using the platform to engage in a two-way conversation, brands discover exactly what people want and how they feel and build a unique journey that connects highly qualified consumers with relevantmessages that generate awareness, motivate intent, and impact purchase decisions. ViralGains is headquartered in Boston, with regional offices in Chicago, Detroit, Los Angeles, San Francisco, and New York. | $12.3M / Series A / Jan 06, 2016 | |
Windgap Medical
|
WindGap Medical is a biotech company that manufactures medical devices used to treat patients with severe allergies. The company develops auto-injectors that are filled with heat-stable epinephrine that enable physicians to inject it into a patient suffering from anaphylaxis due to an acute allergy attack.The company was established in 2011 andis headquartered in Somerville, Massachusetts. | $1.5M / Seed / Apr 28, 2014 | |
InfoBionic
|
InfoBionic transforms the efficiency and the economics of ambulatory remote patient monitoring processes and cardiac diagnostic services by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. It has developed the MoMe System, a remote patient monitoring platform initially focused on cardiacarrhythmia detection, to improve clinical efficiency and patient care with any time, anywhere access to patient data. The company was founded in 2011 and is headquartered in Waltham, Massachusetts. | $17M / Series B / Apr 08, 2014 | |
Kalion
|
Kalion is an early stage industrial biotech company that will transform the traditional chemical industry by providing low-cost access to glucaric acid and S-3-hydroxybutyrolactone (3-HBL) using traditional, green, fermentation technology. Glucaric acid and 3-HBL were identified as “Top Value Added Chemicals from Biomass” and multi-billion dollarmarkets for use of the two chemicals are limited by cost and availability (2004 DOE report). | $300K / Seed / Jan 01, 2014 | |
Fetchnotes
|
Fetchnotes is a productivity application that provides quick note-taking and creates to-do lists. It provides a cloud-based note jotting and organizing system which allows user to capture, organize short notes like books to read, ideas, and shopping lists. | Jan 01, 2014 | |
Avaxia Biologics
|
Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. | $2.9M / Debt Financing / Dec 20, 2013 | |
LoopPay
|
LoopPay is a widely accepted mobile payment provider, empowering consumers to finally leave their physical wallets at home, today. LoopPay’s patented Magnetic Secure Transmission (MST) technology turns existing mag stripe readers into mobile contactless readers without any charge or cost to merchants or their payment processors, enabling securemobile payments at more than 10 million locations in the U.S. Consumers can select from an array of devices that match their phones and fit their lifestyles, including the LoopPay Fob, ChargeCase, CardCase, and Card. In addition, all cards, including payment, gift, loyalty, reward and IDs, can be stored in one place via the LoopPay app, which offers utmost convenience and security, as all data is password and PIN-protected. LoopPay also encrypts and stores all card track data in secure memory within any device and is a Level One PCI Certified Payment Provider. | $10M / Series A / Dec 13, 2013 | |
Covocative
|
Covocative has created a web-based Sales Coaching platform that helps companies improve sales performance by getting the most out of their salespeople.Our software approach makes coaching more effective, more convenient, and more accessible than ever before. For the first time, sales managers and sales reps can use software tools to establishclear professional development objectives, develop action plans for improvement, and receive timely coaching tips - all through the convenience of the same connected devices they use every day.Our sales coaching solutions are a perfect fit for "Sales 2.0" enterprises having a large number of young reps who want coaching and development but who aren't getting it today. Our solutions can also connect distributed teams of enterprise sales professionals, reinforcing a culture of continuous improvement and collaboration.The Covocative Sales Coaching platform uniquely combines the scalability of a cloud-based platform with the domain expertise of proven sales leaders. Our tools and libraries are fully customizable to align with an enterprise's existing sales process, structure, and strategic needs.Sales performance is people performance. Our software solutions ensure salespeople realize their full selling potential by making professional development convenient, effective, and affordable. | Dec 12, 2013 | |
Respiratory Motion
|
Respiratory Motion is a commercial-stage medical device company that specializes in the fields of medical device, clinical evaluation and testing, manufacturing, and respiratory monitoring. The company is developing and commercializing the ExSpiron. RMI’s goal is to cost-effectively improve the standard of care in respiratory monitoring. It wasfounded in 2010 and headquartered in Watertown, Massachusetts. | Dec 01, 2013 | |
| See all 23 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Mobile Investors
12,672 investors
Medical Device Investors
11,047 investors
SaaS VC Funds
61,208 investors
Software VC Funds
31,919 investors
FAQ
What does Beta Fund invest in?
Beta Fund invests primarily in Biotechnology, Mobile and Software startups, most often at Series A and Funding Round stage. Most of the 23 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Beta Fund?
Public channels for Beta Fund include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Beta Fund?
The team at Beta Fund includes Bill Johnson (CFO), Dan Von Kohorn (Principal) and Norman Meisner (Principal). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
